The hormone receptor guanylyl cyclase C (GCC) has been established as a suppressor of colorectal cancer tumors, but new evidence from Thomas Jefferson University suggests it may also help fight one of the country's biggest ...
Aug 25, 2011
0
0
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have published a study in Molecular Cancer Research in which they identify methylation patterns associated with different subtypes of breast cancer, and ...
Jul 19, 2019
0
4
Scientists from the St Petersburg University Laboratory of the Mosaic of Autoimmunity have conducted a comprehensive examination of women who have undergone silicone augmentation mammoplasty. The doctors have found a slight ...
Oct 11, 2023
0
17
Among postmenopausal women with hormone receptor-positive breast cancer, increasing age was associated with a higher risk of death from breast cancer, according to a study in the February 8 issue of JAMA.
Feb 7, 2012
0
0
Researchers at VCU Massey Cancer Center have set their sights on a new therapeutic target for an aggressive form of breast cancer with limited treatment options.
Oct 25, 2022
0
65
Beta-blockers are a group of drugs that slow down our heart rate. They work by blocking the action of stress hormones—adrenaline, noradrenaline—stopping them from binding to receptors on heart cells.
Dec 1, 2021
0
10
Melbourne researchers have discovered that anti-cancer compounds currently in clinical trials for some types of leukaemia could offer hope for treating the most common type of breast cancer.
Jul 8, 2013
1
0
A discovery by scientists at the Salk Institute for Biological Studies might explain why some premature infants fail to respond to existing treatments for a deadly respiratory distress syndrome (RDS) and offers clues for ...
Oct 18, 2011
0
0
Hormone researchers at the University of Houston (UH) have their sights set on providing long-term treatment options for diabetes, obesity and cardiovascular diseases by better understanding estradiol, the most potent naturally ...
Sep 29, 2011
0
0
Estrogen and progesterone receptors, and the gene HER2 – these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.
Apr 10, 2013
0
0
